Diabetic polyneuropathy: Progress in diagnostic strategy and novel target discovery, but stagnation in drug development.


Journal

Journal of diabetes investigation
ISSN: 2040-1124
Titre abrégé: J Diabetes Investig
Pays: Japan
ID NLM: 101520702

Informations de publication

Date de publication:
Jan 2020
Historique:
received: 16 10 2019
revised: 20 11 2019
accepted: 20 11 2019
pubmed: 23 11 2019
medline: 24 10 2020
entrez: 23 11 2019
Statut: ppublish

Résumé

Diagnostic strategy of diabetic polyneuropathy has progressed. In particular, Baba's classification on the severity of diabetic polyneuropathy using nerve conduction study and a point-of-care device of nerve conduction study will realize the objective quantitative evaluation of diabetic polyneuropathy.

Identifiants

pubmed: 31755662
doi: 10.1111/jdi.13188
pmc: PMC6944845
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

25-27

Informations de copyright

© 2019 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd.

Références

J Diabetes Investig. 2018 Nov;9(6):1239-1254
pubmed: 29533535
J Peripher Nerv Syst. 2009 Mar;14(1):1-13
pubmed: 19335534
J Diabetes Investig. 2018 Sep;9(5):1173-1181
pubmed: 29430866
Horm Metab Res. 2006 Jun;38(6):361-7
pubmed: 16823717
J Clin Med. 2019 Feb 28;8(3):null
pubmed: 30823497
J Diabetes Investig. 2019 Mar;10(2):466-474
pubmed: 29975462
Diabet Med. 2012 Dec;29(12):1529-33
pubmed: 22507139
J Diabetes Investig. 2018 Sep;9(5):1033-1040
pubmed: 29412513
J Diabetes Investig. 2018 Mar;9(2):244-255
pubmed: 28779528
J Diabetes Investig. 2018 Sep;9(5):1167-1172
pubmed: 29380548
J Diabetes Res. 2018 Aug 2;2018:5647981
pubmed: 30155488
J Diabetes Investig. 2018 Mar;9(2):383-388
pubmed: 28494142
J Diabetes Investig. 2018 Jan;9(1):186-192
pubmed: 28296226
Cardiovasc Diabetol. 2019 Jun 18;18(1):81
pubmed: 31215496
Lancet. 2013 Mar 2;381(9868):752-62
pubmed: 23395245
Pediatr Diabetes. 2018 Jun;19(4):680-689
pubmed: 29292558
J Diabetes Investig. 2019 Sep;10(5):1291-1298
pubmed: 30659760
Eur J Neurol. 2015 May;22(5):806-14, e55
pubmed: 25623782
J Diabetes Investig. 2019 May;10(3):602-612
pubmed: 30216708
J Diabetes Investig. 2018 Sep;9(5):1016-1018
pubmed: 29277966
J Diabetes Res. 2019 Nov 18;2019:2756020
pubmed: 31828158
J Diabetes Investig. 2018 Jan;9(1):179-185
pubmed: 28267271

Auteurs

Tatsuhito Himeno (T)

Division of Diabetes, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Japan.

Hideki Kamiya (H)

Division of Diabetes, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Japan.

Jiro Nakamura (J)

Division of Diabetes, Department of Internal Medicine, Aichi Medical University School of Medicine, Nagakute, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH